HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan.

Abstract
We surveyed the incidence of amantadine-resistant influenza A viruses both at sentinel surveillance sites and at nursing homes, and verified their types of change by partial nucleotide sequence analysis of the M2 protein. Fifty-five influenza A viruses from 27 sentinel surveillance sites during six influenza seasons from 1993 to 1999, and 26 influenza A viruses from 5 nursing homes from 1996 to 1999 were examined for susceptibility to the drug by virus titration in the presence or absence of amantadine. While amantadine-resistant viruses were not found in sentinel surveillance sites, a high frequency of resistance (8/26, 30.8%) in nursing homes was observed. Resistant viruses can occur quickly and be transmitted when used in an outbreak situation at nursing homes, where amantadine is used either for neurologic indications or for influenza treatment. Eight resistant viruses had a single amino acid change of the M2 protein at residue 30 or 31. In vitro, all 11 sensitive viruses turned resistant after 3 or 5 passages in the presence of 2 microg/ml amantadine, and they showed an amino acid change at residue 27, 30, or 31. The predominant amino acid substitution in the M2 protein of resistant viruses is Ser-31-Asp (a change at 31, serine to asparagine). The results indicate that a monitoring system for amantadine-resistant influenza viruses should be established without delay in Japan.
AuthorsH Masuda, H Suzuki, H Oshitani, R Saito, S Kawasaki, M Nishikawa, H Satoh
JournalMicrobiology and immunology (Microbiol Immunol) Vol. 44 Issue 10 Pg. 833-9 ( 2000) ISSN: 0385-5600 [Print] Australia
PMID11128067 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • M-protein, influenza virus
  • M2 protein, Influenza A virus
  • Viral Matrix Proteins
  • Amantadine
Topics
  • Amantadine (pharmacology)
  • Antiviral Agents (pharmacology)
  • Drug Resistance, Microbial
  • Humans
  • Incidence
  • Influenza A virus (drug effects, genetics)
  • Influenza, Human (epidemiology, virology)
  • Japan (epidemiology)
  • Nursing Homes
  • Sentinel Surveillance
  • Sequence Analysis, DNA
  • Viral Matrix Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: